FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892908130> ?p ?o ?g. }

• W2892908130 endingPage "17" @default.
• W2892908130 startingPage "10" @default.
• W2892908130 abstract "The best preventive strategy for canine leishmaniasis is, to date, unknown. In the last few years, new preventive measures have become available in Europe, including vaccination against leishmaniasis and the use of domperidone. The objective of the present study was to evaluate the efficacy and safety of the different preventive measures available against leishmaniasis in client-owned dogs. A database search of medical records was carried out in 52 private veterinary practices located in endemic areas of canine leishmaniasis in Spain, Italy and Portugal. Healthy seronegative dogs were included in the study. Serology was repeated at least 6 months later, and was used to retrospectively classify dogs into healthy, infected or sick. A total of 1647 dogs were included in the study. The use of preventive measures in this population was widespread. The single most utilized measure was repellents alone in 45.7% of dogs, followed by the combination of repellents and vaccination in 23.0%, repellents and domperidone in 11.3%, vaccination alone in 4.2%, vaccination and domperidone in 2.7%, domperidone alone in 2.3%, and the combination of the three measures in 0.2% of dogs. No preventive measure was applied in 10.7% dogs. The incidence of clinical leishmaniasis in the group with no preventive treatment applied was 12.5%. In the groups where prevention was applied, the reported incidence was the following: 10.1% for the vaccination only group, 4.5% for repellents only group, 4.0% for repellents + vaccination group, and 0.5% for repellents + domperidone group. No dogs in the groups of domperidone, vaccination + domperidone, and combination of the three measures developed clinical leishmaniasis. All preventive measures resulted in a significantly lower incidence of leishmaniasis compared to not applying any measure, except for vaccination alone. The majority of preventive strategies used, with exception of vaccination alone, decreased the incidence of leishmaniasis significantly. Adverse events, mild and self-limiting in most of the cases, were reported in 5.2% of dogs and were significantly more common in dogs following vaccination. In conclusion, this is the first large-scale field study investigating the efficacy and safety of the preventive measures used routinely against leishmaniasis in client-owned dogs. Most preventive strategies used, with exception of vaccination alone, had some benefit over not applying any preventive. In this field study, the use of repellents showed a good degree of protection in dogs living in endemic areas of canine leishmaniasis. Although lower numbers of dogs are included, the use of domperidone appeared to provide additional protection. The role of vaccination and its combination with other preventive strategies needs further study." @default.
• W2892908130 created "2018-10-05" @default.
• W2892908130 creator A5004958967 @default.
• W2892908130 creator A5020408377 @default.
• W2892908130 creator A5022431894 @default.
• W2892908130 creator A5031480715 @default.
• W2892908130 creator A5031828651 @default.
• W2892908130 creator A5070056284 @default.
• W2892908130 date "2018-11-01" @default.
• W2892908130 modified "2023-09-27" @default.
• W2892908130 title "Comparison of efficacy and safety of preventive measures used against canine leishmaniasis in southern European countries: Longitudinal retrospective study in 1647 client-owned dogs (2012–2016)" @default.
• W2892908130 cites W1614161003 @default.
• W2892908130 cites W1967004002 @default.
• W2892908130 cites W1982566153 @default.
• W2892908130 cites W1991323243 @default.
• W2892908130 cites W2004942991 @default.
• W2892908130 cites W2007024121 @default.
• W2892908130 cites W2011453212 @default.
• W2892908130 cites W2013094917 @default.
• W2892908130 cites W2015360220 @default.
• W2892908130 cites W2020112347 @default.
• W2892908130 cites W2023756444 @default.
• W2892908130 cites W2025899290 @default.
• W2892908130 cites W2026685638 @default.
• W2892908130 cites W2035010023 @default.
• W2892908130 cites W2037924824 @default.
• W2892908130 cites W2038771703 @default.
• W2892908130 cites W2080975571 @default.
• W2892908130 cites W2090329903 @default.
• W2892908130 cites W2092793728 @default.
• W2892908130 cites W2107915297 @default.
• W2892908130 cites W2109273603 @default.
• W2892908130 cites W2116006578 @default.
• W2892908130 cites W2118670450 @default.
• W2892908130 cites W2125345027 @default.
• W2892908130 cites W2126023291 @default.
• W2892908130 cites W2128166966 @default.
• W2892908130 cites W2128620073 @default.
• W2892908130 cites W2135592181 @default.
• W2892908130 cites W2141214142 @default.
• W2892908130 cites W2141800850 @default.
• W2892908130 cites W2143184055 @default.
• W2892908130 cites W2221630639 @default.
• W2892908130 cites W2298988754 @default.
• W2892908130 cites W2344038770 @default.
• W2892908130 cites W2400858947 @default.
• W2892908130 cites W2465280594 @default.
• W2892908130 cites W2520600377 @default.
• W2892908130 cites W2558720014 @default.
• W2892908130 cites W2622167245 @default.
• W2892908130 cites W2624285072 @default.
• W2892908130 cites W2724999405 @default.
• W2892908130 cites W2756541028 @default.
• W2892908130 cites W2791885900 @default.
• W2892908130 cites W2807498849 @default.
• W2892908130 doi "https://doi.org/10.1016/j.vetpar.2018.09.014" @default.
• W2892908130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30389018" @default.
• W2892908130 hasPublicationYear "2018" @default.
• W2892908130 type Work @default.
• W2892908130 sameAs 2892908130 @default.
• W2892908130 citedByCount "8" @default.
• W2892908130 countsByYear W28929081302020 @default.
• W2892908130 countsByYear W28929081302021 @default.
• W2892908130 countsByYear W28929081302022 @default.
• W2892908130 countsByYear W28929081302023 @default.
• W2892908130 crossrefType "journal-article" @default.
• W2892908130 hasAuthorship W2892908130A5004958967 @default.
• W2892908130 hasAuthorship W2892908130A5020408377 @default.
• W2892908130 hasAuthorship W2892908130A5022431894 @default.
• W2892908130 hasAuthorship W2892908130A5031480715 @default.
• W2892908130 hasAuthorship W2892908130A5031828651 @default.
• W2892908130 hasAuthorship W2892908130A5070056284 @default.
• W2892908130 hasConcept C120665830 @default.
• W2892908130 hasConcept C121332964 @default.
• W2892908130 hasConcept C126322002 @default.
• W2892908130 hasConcept C203014093 @default.
• W2892908130 hasConcept C22070199 @default.
• W2892908130 hasConcept C2775995038 @default.
• W2892908130 hasConcept C2776555147 @default.
• W2892908130 hasConcept C2777625542 @default.
• W2892908130 hasConcept C2778689377 @default.
• W2892908130 hasConcept C2781257258 @default.
• W2892908130 hasConcept C2908647359 @default.
• W2892908130 hasConcept C42972112 @default.
• W2892908130 hasConcept C513476851 @default.
• W2892908130 hasConcept C61511704 @default.
• W2892908130 hasConcept C71924100 @default.
• W2892908130 hasConcept C99454951 @default.
• W2892908130 hasConceptScore W2892908130C120665830 @default.
• W2892908130 hasConceptScore W2892908130C121332964 @default.
• W2892908130 hasConceptScore W2892908130C126322002 @default.
• W2892908130 hasConceptScore W2892908130C203014093 @default.
• W2892908130 hasConceptScore W2892908130C22070199 @default.
• W2892908130 hasConceptScore W2892908130C2775995038 @default.
• W2892908130 hasConceptScore W2892908130C2776555147 @default.
• W2892908130 hasConceptScore W2892908130C2777625542 @default.
• W2892908130 hasConceptScore W2892908130C2778689377 @default.
• W2892908130 hasConceptScore W2892908130C2781257258 @default.

• next